These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 24972536

  • 1. Spasmodic dysphonia: let's look at that again.
    Murry T.
    J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
    [Abstract] [Full Text] [Related]

  • 2. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM, Hapner ER, Klein AM, Pethan M, Johns MM.
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [Abstract] [Full Text] [Related]

  • 3. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE, Ricz H, Tumas V, Rodrigues GR, Toscano P, Aguiar-Ricz L.
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [Abstract] [Full Text] [Related]

  • 4. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
    Orbelo DM, Duffy JR, Hughes Borst BJ, Ekbom D, Maragos NE.
    J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
    [Abstract] [Full Text] [Related]

  • 5. Automated acoustic analysis of task dependency in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N, Mazin A, Awan SN.
    Laryngoscope; 2014 Mar; 124(3):718-24. PubMed ID: 23946147
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.
    Rosow DE, Pechman A, Saint-Victor S, Lo K, Lundy DS, Casiano RR.
    J Voice; 2015 May; 29(3):352-5. PubMed ID: 25242042
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
    Morzaria S, Damrose EJ.
    J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
    [Abstract] [Full Text] [Related]

  • 8. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA, Leonard RJ.
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [Abstract] [Full Text] [Related]

  • 9. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
    Young DL, Halstead LA.
    J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039
    [Abstract] [Full Text] [Related]

  • 10. Behavior Assessment Battery: A Pilot Study of the Affective, Behavioral, and Cognitive Correlates Surrounding Spasmodic Dysphonia.
    Vanryckeghem M, Hoffman Ruddy B, Lehman J.
    J Voice; 2016 Jan; 30(1):53-60. PubMed ID: 26209041
    [Abstract] [Full Text] [Related]

  • 11. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
    Chen W, Woo P, Murry T.
    J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
    [Abstract] [Full Text] [Related]

  • 12. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU.
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB, Lee CT, Hatcher JL, Michalek J.
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [Abstract] [Full Text] [Related]

  • 14. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
    Crevier-Buchman L, Laccourreye O, Papon JF, Nurit D, Brasnu D.
    J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
    [Abstract] [Full Text] [Related]

  • 15. Laryngeal dystonia gravidarum: sudden onset of adductor spasmodic dysphonia in pregnancy.
    Ankola A, Sulica L, Murry T.
    Laryngoscope; 2013 Dec; 123(12):3127-30. PubMed ID: 23712421
    [Abstract] [Full Text] [Related]

  • 16. Sulcus vocalis in spasmodic dysphonia-A retrospective study.
    Nerurkar NK, Agrawal D, Joshi D.
    Am J Otolaryngol; 2021 Dec; 42(3):102940. PubMed ID: 33545449
    [Abstract] [Full Text] [Related]

  • 17. Spasmodic Dysphonia.
    Lin J, Sadoughi B.
    Adv Otorhinolaryngol; 2020 Dec; 85():133-143. PubMed ID: 33166970
    [Abstract] [Full Text] [Related]

  • 18. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM, Case JL, Ludlow CL.
    J Commun Disord; 2001 Dec; 34(1-2):21-37. PubMed ID: 11322567
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Thompson AR.
    J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
    [Abstract] [Full Text] [Related]

  • 20. Inferring speaker attributes in adductor spasmodic dysphonia: ratings from unfamiliar listeners.
    Isetti D, Xuereb L, Eadie TL.
    Am J Speech Lang Pathol; 2014 May; 23(2):134-45. PubMed ID: 24686338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.